Reactivation of human herpes virus-6 in the renal tissue of a patient with drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms (DIHS/DRESS)

Internal Medicine

Volumn 55, Issue 13, 2016, Pages 1769-1774

  Hagiya, Hideharu ^a   Iwamuro, Masaya ^a   Tanaka, Takehiro ^a   Hasegawa, Kou ^a   Hanayama, Yoshihisa ^a   Kimura, Maya ^a   Otsuka, Fumio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Drug rash with eosinophilia and systemic symptoms (DRESS); Drug induced hypersensitivity syndrome (DIHS); Eosinophilia; Human herpes virus 6 (HHV 6); Reactivation

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CEFAZOLIN; COTRIMOXAZOLE; CREATININE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; N ACETYL BETA GLUCOSAMINIDASE; PREDNISOLONE; ANTIINFECTIVE AGENT; CORTICOSTEROID;

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LUNG EMBOLISM; LYMPHADENOPATHY; MALE; POLYMERASE CHAIN REACTION; PROSTATITIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; STAPHYLOCOCCAL BACTEREMIA; VIRUS REACTIVATION; COMPLICATION; DRUG HYPERSENSITIVITY SYNDROME; EOSINOPHILIA; KIDNEY FAILURE; PHYSIOLOGY; VIROLOGY;

ADRENAL CORTEX HORMONES; AGED; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY SYNDROME; EOSINOPHILIA; HERPESVIRUS 6, HUMAN; HUMANS; MALE; RENAL INSUFFICIENCY; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84976530068     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.6287     Document Type: Article

References (27)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 331: 1272-1285, 1994.
2. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 124: 588-597, 2011.
3. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human Herpesvirus 6 infection as a risk factor for the development of severe drug-Induced hypersensitivity syndrome. Arch Dermatol 134: 1108-1112, 1998.
4. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134: 1113-1117, 1998.
5. Ushigome Y, Kano Y, Hirahara K, Shiohara T. Human herpesvirus 6 reactivation in drug-Induced hypersensitivity syndrome and DRESS validation score. Am J Med 125: e9-e10, 2012.
6. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (Dihs): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 55: 1-8, 2006.
7. Saraya T, Mikoshiba M, Kamiyama H, et al. Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-Induced hypersensitivity syndrome. J Clin Microbiol 51: 1979-1982, 2013.
8. Miyashita K, Shobatake C, Miyagawa F, et al. Involvement of human herpesvirus 6 infection in renal dysfunction associated with DIHS/DRESS. Acta Derm Venereol 96: 114-115, 2016.
9. Pellett PE, Sanchez-Martinez D, Dominguez G, et al. A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: identification and characterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope. Virology 195: 521-531, 1993.
10. Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med 366: 2492-2501, 2012.
11. Bouvresse S, Valeyrie-Allanore L, Ortonne N, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis 7: 72, 2012.
12. Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 149: 1018-1022, 2003.
13. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 206: 353-356, 2003.
14. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. management and therapeutics. J Am Acad Dermatol 68: 709 e701-e709; quiz 718-720, 2013.
15. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156: 609-611, 2007.
16. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156: 1083-1084, 2007.
17. Hicks ME, Smith CL, Stein GE. Trimethoprim/sulfamethoxazoleinduced hypersensitivity syndrome. Ann Pharmacother 31: 1259, 1997.
18. Mainra RR, Card SE. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - Part of a Hypersensitivity Syndrome. Can J Clin Pharmacol 10: 175-178, 2003.
19. Morimoto T, Sato T, Matsuoka A, et al. Trimethoprimsulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Intern Med 45: 101-105, 2006.
20. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157: 934-940, 2007.
21. Wade AW, McDonald AT, Acott PD, Lee S, Crocker JF. Human herpes virus-6 or Epstein-Barr virus infection and acute allograft rejection in pediatric kidney transplant recipients: greater risk for immunologically naive recipients. Transplant Proc 30: 2091-2093, 1998.
22. Augusto JF, Sayegh J, Simon A, et al. A case of sulphasalazineinduced DRESS syndrome with delayed acute interstitial nephritis. Nephrol Dial Transplant 24: 2940-2942, 2009.
23. Sura R, Gavrilov B, Flamand L, et al. Human herpesvirus-6 in patients with Crohn’s disease. APMIS 118: 394-400, 2010.
24. Hashizume H, Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol 85: 47-50, 2005.
25. Naniwa T, Maeda S, Sawada H, et al. Drug-induced hypersensitiveity syndrome associated with a marked increase in antiparamyxovirus antibody titers in a scleroderma patient. Allergol Int 56: 303-308, 2007.
26. Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2: 46ra62, 2010.
27. Mostella J, Pieroni R, Jones R, Finch CK. Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin. South Med J 97: 319-321, 2004.